Semaglutide 5mg/10mg Research Peptide

Third-Party Tested
≥98% Purity
Fast Shipping
COA Included

For research and laboratory use only. Not for human consumption. By purchasing, you confirm you are a qualified researcher.

$80.00

Shipping and returns

Authorities in our business will tell in no uncertain terms that Lorem Ipsum is that huge, huge no no to forswear forever. Not so fast, I'd say, there are some redeeming factors in favor of greeking text, as its use is merely the symptom of a worse problem to take into consideration.

Product care

Anyway, you still use Lorem Ipsum and rightly so, as it will always have a place in the web workers toolbox, as things happen, not always the way you like it, not always in the preferred order.

Product details

Made possible by exploring innovative molded plywood techniques, Iskos-Berlin’s Soft Edge Chair blends strong curves with extreme lightness to create a three-dimensionality not usually possible with 2-D plywood.

Description

For Research Purposes Only. Not approved for human consumption.

Semaglutide Research Peptide 5mg

Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist developed by Novo Nordisk, representing the current standard for single-mechanism metabolic peptide research. It mimics endogenous GLP-1 with 94% homology but with extended half-life (~165 hours) due to albumin binding via a C-18 fatty di-acid side chain. With extensive Phase 3 data across diabetes (SUSTAIN trials) and obesity (STEP trials), Semaglutide serves as a benchmark comparator for researchers studying newer metabolic peptides including Tirzepatide and Retatrutide.

Research Applications

  • GLP-1 receptor biology and signaling research
  • Diabetes and glucose metabolism studies
  • Obesity and weight regulation research
  • Gastric motility and satiety mechanism studies
  • Comparative metabolic peptide efficacy studies

Quality Specifications

  • Purity: ≥98% (HPLC verified)
  • Compound: Semaglutide
  • Molecular Weight: 4113.6 Da
  • Form: Lyophilized powder
  • Storage: -20°C, protect from light
  • COA: Batch-specific, ISO-accredited laboratory

Frequently Asked Questions

Q: How does Semaglutide differ from native GLP-1?
A: 94% homology to human GLP-7-37 but with a C-18 fatty di-acid side chain enabling albumin binding. This extends half-life from minutes to ~165 hours, allowing weekly administration in research.

Q: What is Semaglutide’s research significance?
A: Extensive Phase 3 data makes it the benchmark GLP-1 agonist. Researchers use it as a comparator when studying newer compounds like Tirzepatide (dual agonist) and Retatrutide (triple agonist).

Q: How does Semaglutide work mechanically?
A: Activates GLP-1 receptors in the pancreas (glucose-dependent insulin secretion), hypothalamus (appetite regulation), and GI tract (delayed gastric emptying).

Related Research: Tirzepatide Research Peptide | Retatrutide Triple Agonist | Metabolic Research 2026 | Cagrilintide Research Peptide | AOD-9604 Research Peptide | Retatrutide Complete Research Guide | Are Research Peptides Legal? | What Is a COA?

For laboratory research use only. Not for human consumption. Not evaluated by the FDA.

Customer Reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “Semaglutide 5mg/10mg Research Peptide”

Your email address will not be published. Required fields are marked *